172 related articles for article (PubMed ID: 38464825)
1. Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating LKB1/AMPK signaling.
Kou B; Shi Y; Zhou Z; Yun Y; Wu Q; Zhou J; Liu W
Int J Med Sci; 2024; 21(4):623-632. PubMed ID: 38464825
[TBL] [Abstract][Full Text] [Related]
2. Oridonin inhibits epithelial-mesenchymal transition of human nasopharyngeal carcinoma cells by negatively regulating AKT/STAT3 signaling pathway.
Liu W; Huang G; Yang Y; Gao R; Zhang S; Kou B
Int J Med Sci; 2021; 18(1):81-87. PubMed ID: 33390776
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway.
Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W
Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793
[TBL] [Abstract][Full Text] [Related]
4. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling.
Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
[TBL] [Abstract][Full Text] [Related]
5. Oridonin Induces Apoptosis of Laryngeal Carcinoma via Endoplasmic Reticulum Stress.
Kou B; Yang Y; Bai YE; Shi YH; Gao RX; Yang FL; Zhang SQ; Liu W
Cancer Manag Res; 2020; 12():8387-8396. PubMed ID: 32982432
[TBL] [Abstract][Full Text] [Related]
6. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
7. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma.
Sun Y; Jiang X; Lu Y; Zhu J; Yu L; Ma B; Zhang Q
Chem Biol Interact; 2018 Dec; 296():57-64. PubMed ID: 30243739
[TBL] [Abstract][Full Text] [Related]
8. MiR-199a-5p suppresses proliferation and invasion of human laryngeal cancer cells.
Li DJ; Wang X; Yin WH; Niu K; Zhu W; Fang N
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12200-12207. PubMed ID: 33336738
[TBL] [Abstract][Full Text] [Related]
9. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract][Full Text] [Related]
10. Oridonin inhibits the migration and epithelial-to-mesenchymal transition of small cell lung cancer cells by suppressing FAK-ERK1/2 signalling pathway.
Xu L; Bi Y; Xu Y; Zhang Z; Xu W; Zhang S; Chen J
J Cell Mol Med; 2020 Apr; 24(8):4480-4493. PubMed ID: 32168416
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells.
Kang N; Cao SJ; Zhou Y; He H; Tashiro S; Onodera S; Qiu F; Ikejima T
Int J Oncol; 2015 Dec; 47(6):2045-56. PubMed ID: 26648189
[TBL] [Abstract][Full Text] [Related]
12. WISP1 aggravates cell metastatic potential by abrogating TGF-
Song D; Wang L; Su K; Wu H; Li J
Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
[TBL] [Abstract][Full Text] [Related]
13. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells.
Liu S; Zhou F; Shen Y; Zhang Y; Yin H; Zeng Y; Liu J; Yan Z; Liu X
Oncotarget; 2016 May; 7(22):32876-92. PubMed ID: 27096955
[TBL] [Abstract][Full Text] [Related]
14. Ribophorin II promotes the epithelial-mesenchymal transition and aerobic glycolysis of laryngeal squamous cell carcinoma via regulating reactive oxygen species-mediated Phosphatidylinositol-3-Kinase/Protein Kinase B activation.
Zhou J; Zhang J; Zhang W; Ke Z; Lv Y; Zhang B; Liao Z
Bioengineered; 2022 Mar; 13(3):5141-5151. PubMed ID: 35156537
[TBL] [Abstract][Full Text] [Related]
15. KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells through NF-κB signaling pathway.
Liu FF; Dong L; Yang X; Li DJ; Shen YY; Liu ZL
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3867-3875. PubMed ID: 31115014
[TBL] [Abstract][Full Text] [Related]
16. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.
Chen K; Ye J; Qi L; Liao Y; Li R; Song S; Zhou C; Feng R; Zhai W
Anticancer Drugs; 2019 Oct; 30(9):925-932. PubMed ID: 31517732
[TBL] [Abstract][Full Text] [Related]
17. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
18. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
[TBL] [Abstract][Full Text] [Related]
19. Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.
Che X; Zhan J; Zhao F; Zhong Z; Chen M; Han R; Wang Y
Biomed Res Int; 2021; 2021():4340950. PubMed ID: 34285910
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
